---
search:
  boost: 2 
---

# Glaucoma Agents

This is a subcategory of Ophthalmic Agents.

## Formulary

### Preferred

| Preferred                       | Generic Name | Quantity | Time (Days) |
| :------------------------------ | :----------- | :------: | :---------: |
| Alphagan P 0.1%                 |              |          |             |
| Alphagan P 0.15% <sup>BvG</sup> |              |          |             |
| Azopt <sup>BvG ST</sup>         |              |          |             |
| Betaxolol                       |              |          |             |
| Betaxolol                       |              |          |             |
| Brimonidine 0.2%                |              |          |             |
| Carteolol                       |              |          |             |
| Combigan <sup>BvG ST</sup>      |              |          |             |
| Dorzolamide                     |              |          |             |
| Dorzolamide / Timolol           |              |          |             |
| Latanaprost                     |              |          |             |
| Levobunolol                     |              |          |             |
| Metipranolol                    |              |          |             |
| Rhopressa                       |              |          |             |
| Rocklatan                       |              |          |             |
| Simbrinza                       |              |          |             |
| Timolol                         |              |          |             |
| Timolol                         |              |          |             |
| Travatan Z <sup>BvG ST</sup>    |              |          |             |

### Non-Preferred

| Non-Preferred     | Generic Name | Quantity | Time (Days) |
| :---------------- | :----------- | :------: | :---------: |
| Apraclonidine     |              |          |             |
| Betoptic S        |              |          |             |
| Bimatoprost       |              |          |             |
| Brimonidine 0.15% |              |          |             |
| Brinzolamide      |              |          |             |
| Iopidine          |              |          |             |
| Istalol           |              |          |             |
| Lumigan           |              |          |             |
| Travoprost        |              |          |             |
| Vyzulta           |              |          |             |
| Xelpros           |              |          |             |
| Zioptan           |              |          |             |

## Authorizations

**Length of Authorizations**: 365 Days

**All Authorizations**: Must be prescribed in accordance with FDA approved labeling

## Criteria

### Step Therapy

Step Therapy Approval Criteria

- Must have had an inadequate clinical response of at least 30 days with at least one
preferred drug in the same class, if available

### Non-Preferred

Non-Preferred Criteria

- Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    - For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
- Must have had an inadequate clinical response of at least **30 days** with at least **two preferred** drugs in the same class, if available
    - For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    - For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)

### Subsequent Authorization

Subsequent Authorization Criteria

- Must provide documentation of patient's clinical response to treatment and ongoing safety monitoring

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_UPDL%20_Criteria_APPROVED.pdf#page=87)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_UPDL_APPROVED_12.13.22.pdf#page=29)

[Quantity Limit List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_Ohio_Medicaid_Quantity_Document_APPROVED.pdf)
